On a DEA 222 form, which corrections are permitted by the supplier?

The ability to correct a misspelling of the drug name on a DEA 222 form is permitted for the supplier because it ensures that the order accurately reflects the drug being requested. Such corrections are critical to maintaining the integrity and clarity of the documentation, which is essential in the controlled substances ordering process. Accurate drug identification helps prevent errors in filling the prescription and ensures adherence to regulatory requirements.

Change of other details, such as modifying the quantity, adding a new line item, or altering the date, is not allowed because these changes could potentially lead to confusion or misuse of the form. The regulations emphasize the importance of maintaining original entries to prevent discrepancies and uphold the legal standards associated with controlled substances.